Sveriges mest populÀra poddar
Flot.bio x Philip Hemme

Marc de Garidel, Abivax đŸ‡«đŸ‡· | Ulcerative Colitis, Inflammation | E46

54 min‱17 november 2025

When Abivax released stunning phase 3 results for ulcerative colitis, its 600% stock price surge froze Euronext for 45 minutes.

Philip meets Abivax CEO Marc de Garidel in Vienna, Austria, to go behind the scenes of a remarkable biotech turnaround.

Marc discusses the processes involved in executing the phase 3 trial that beat even Abivax’s own phase 2 data. He also talks about France’s biotech ecosystem and the importance of having the right team.


⭐ ABOUT THE SPEAKER

Marc de Garidel joined Abivax as CEO in 2023. Prior to this, he led two biotech companies through billion-dollar exits (CinCor Pharma and Corvidia Therapeutics). He also served as CEO of Ipsen from 2010 to 2016, and has worked at the likes of Amgen and Eli Lilly.


🔗 LINKS MENTIONED


📜 TRANSCRIPT

Read the full transcript here:


💾 DONATE

We welcome donations from individuals and businesses to support our podcast and allow us to create even more content: https://www.paypal.me/PhilipHemme


⭐ SPONSORSHIP

Ready to amplify your brand to influential leaders in biotech and biopharma? Contact [email protected] and unlock sponsorship opportunities in our podcasts!


đŸ«¶ FOLLOW US


🙏 LIKE/FOLLOW/REVIEW

Did you enjoy the episode? Please hit the like and subscribe button. Also, please let me know your thoughts in the comments below.


đŸŽ™ïžÂ ABOUT FLOT.BIO

Flot.bio is a show to watch the best Europeans in biotech to help you grow. Hosted by Philip Hemme. 25k monthly views. Free.


⏰ TIMESTAMPS

  • 0:44: Abivax’s crazy Ph3 data and stock price jump
  • 4:06: Surging investor demand on NASDAQ and Euronext
  • 8:58: Future directions
  • 11:02: Executing a Phase 3 home run
  • 17:20: Marc de Garidel's leadership style
  • 21:58: Abivax: origins
  • 34:51: France's billion-dollar biotechs
  • 44:11: Quick-fire questions

Flot.bio x Philip Hemme med Flot.bio finns tillgÀnglig pÄ flera plattformar. Informationen pÄ denna sida kommer frÄn offentliga podd-flöden.